Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Bose, Amal K; Mocanu, Mihaela M; Carr, Richard D; Brand, Christian L; Yellon, Derek MDiabetes; 2005 Jan;54(1):146-51. PMID: 15616022Category: GLP-1s
Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism. Nyström, Thomas; Gonon, Adrian T; Sjöholm, Ake; Pernow, JohnRegulatory peptides; 2005 Feb 15;125(1-3):173-7. PMID: 15582729Category: GLP-1s
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Nyström, Thomas; Gutniak, Mark K; Zhang, Qimin; Zhang, Fan; Holst, Jens Juul; Ahrén, Bo; Sjöholm, AkeAmerican journal of physiology. Endocrinology and metabolism; 2004 Dec;287(6):E1209-15. PMID: 15353407Category: GLP-1s
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Buse, John B; Henry, Robert R; Han, Jenny; Kim, Dennis D; Fineman, Mark S; Baron, Alain D; , Diabetes care; 2004 Nov;27(11):2628-35. PMID: 15504997Category: GLP-1s
One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes. Degn, Kristine B; Juhl, Claus B; Sturis, Jeppe; Jakobsen, Grethe; Brock, Birgitte; Chandramouli, Visvanathan; Rungby, Joergen; Landau, Bernard R; Schmitz, OleDiabetes; 2004 May;53(5):1187-94. PMID: 15111485Category: GLP-1s
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Nikolaidis, Lazaros A; Mankad, Sunil; Sokos, George G; Miske, Glen; Shah, Ankur; Elahi, Dariush; Shannon, Richard PCirculation; 2004 Mar 2;109(8):962-5. PMID: 14981009Category: GLP-1s
Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Farilla, Loredana; Bulotta, Angela; Hirshberg, Boaz; Li Calzi, Sergio; Khoury, Nasif; Noushmehr, Houtan; Bertolotto, Cristina; Di Mario, Umberto; Harlan, David M; Perfetti, RiccardoEndocrinology; 2003 Dec;144(12):5149-58. PMID: 12960095Category: GLP-1s
Enhancing incretin action for the treatment of type 2 diabetes. Drucker, Daniel JDiabetes care; 2003 Oct;26(10):2929-40. PMID: 14514604Category: GLP-1s
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. During, Matthew J; Cao, Lei; Zuzga, David S; Francis, Jeremy S; Fitzsimons, Helen L; Jiao, Xiangyang; Bland, Ross J; Klugmann, Matthias; Banks, William A; Drucker, Daniel J; Haile, Colin NNature medicine; 2003 Sep;9(9):1173-9. PMID: 12925848Category: GLP-1s
Glucagon-like peptide-1 (7-36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium. Kavianipour, Mohammad; Ehlers, Mario R; Malmberg, Klas; Ronquist, Gunnar; Ryden, Lars; Wikström, Gerhard; Gutniak, MarkPeptides; 2003 Apr;24(4):569-78. PMID: 12860201Category: GLP-1s